February 11, 2008

SpeculatingStocks.com Stock Pick: Neostem, Inc. (NBS)

Stock Price: $1.54

NeoStem, Inc. is managing a growing nationwide network of adult stem cell collection centers, enabling people to donate and store their own (autologous) stem cells when they are young and healthy for their personal use in times of future medical need. The company has also recently entered the research and development and therapeutic arenas.

NBS is a very early stage AMEX listed stem cell research and storage company. Neostem is working with an early-stage technology to identify and isolate rare stem cells from adult human marrow, called VSELs (very small embryonic-like stem cells). These cells have shown to have several physical characteristics that are generally found in embryonic stem cells.

NBS is trading at a market cap of only around $7.08 million and has cash on the balance sheet of $3.64 million and very little long-term debt of $22,000. NBS has a book value of $0.86.

NBS has stem cell collection centers in Encinitas, California, Bethlehem, Pennsylvania and Las Vegas, Nevada and recently expanded their stem cell collection center network to Henderson, NV. The company plans to open more stem cell collection centers in 2008.

NBS is at a nice position in its chart and should receive further attention moving forward.